AU2608201A - Compounds for immunotherapy and diagnosis of colon cancer and methods for their use - Google Patents
Compounds for immunotherapy and diagnosis of colon cancer and methods for their useInfo
- Publication number
- AU2608201A AU2608201A AU26082/01A AU2608201A AU2608201A AU 2608201 A AU2608201 A AU 2608201A AU 26082/01 A AU26082/01 A AU 26082/01A AU 2608201 A AU2608201 A AU 2608201A AU 2608201 A AU2608201 A AU 2608201A
- Authority
- AU
- Australia
- Prior art keywords
- immunotherapy
- diagnosis
- compounds
- methods
- colon cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010009944 Colon cancer Diseases 0.000 title 1
- 208000029742 colonic neoplasm Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47629699A | 1999-12-30 | 1999-12-30 | |
US09476296 | 1999-12-30 | ||
US48032100A | 2000-01-10 | 2000-01-10 | |
US09480321 | 2000-01-10 | ||
US50462900A | 2000-02-15 | 2000-02-15 | |
US09504629 | 2000-02-15 | ||
US51944400A | 2000-03-06 | 2000-03-06 | |
US09519444 | 2000-03-06 | ||
US57525100A | 2000-05-19 | 2000-05-19 | |
US09575251 | 2000-05-19 | ||
US60944800A | 2000-06-29 | 2000-06-29 | |
US09609448 | 2000-06-29 | ||
US64981100A | 2000-08-28 | 2000-08-28 | |
US09649811 | 2000-08-28 | ||
PCT/US2000/035596 WO2001049716A2 (en) | 1999-12-30 | 2000-12-29 | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2608201A true AU2608201A (en) | 2001-07-16 |
Family
ID=27569804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26082/01A Abandoned AU2608201A (en) | 1999-12-30 | 2000-12-29 | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1242598A2 (en) |
AU (1) | AU2608201A (en) |
CA (1) | CA2396036A1 (en) |
WO (1) | WO2001049716A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU784548B2 (en) * | 2001-03-16 | 2006-04-27 | Ortho-Clinical Diagnostics, Inc. | Reg-like protein |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962779B1 (en) | 1998-10-02 | 2005-11-08 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
EP1285071A2 (en) * | 2000-05-15 | 2003-02-26 | Emory University | Novel dual oxidases as mitogenic and endocrine regulators |
AU2001269766A1 (en) * | 2000-06-09 | 2001-12-24 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US6635750B1 (en) * | 2000-07-20 | 2003-10-21 | Millennium Pharmaceuticals, Inc. | B7-H2 nucleic acids, members of the B7 family |
AU2001285568A1 (en) * | 2000-07-28 | 2002-03-22 | Michael Andrew Mcguckin | Mucin |
AU2001294999A1 (en) * | 2000-08-07 | 2002-02-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US20030219768A1 (en) * | 2001-11-02 | 2003-11-27 | Beebe Jean S. | Lung cancer therapeutics and diagnostics |
GB0130720D0 (en) * | 2001-12-21 | 2002-02-06 | Serono Internat S A | Proteins |
DE10230631A1 (en) * | 2002-07-02 | 2004-01-22 | Metagen Pharmaceuticals Gmbh | Uses of Ngal-binding substances for the diagnosis and treatment of cancer |
TWI340168B (en) * | 2003-05-07 | 2011-04-11 | Tosoh Corp | Method of detecting micrometastasis |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
US8535677B2 (en) | 2006-06-06 | 2013-09-17 | Oxford Biotherapeutics, Ltd. | Antibody drug conjugate treatment of colorectal cancer |
EP2078202B1 (en) * | 2006-08-29 | 2017-03-08 | Oxford BioTherapeutics Ltd | Protein |
CN106188295A (en) | 2009-04-20 | 2016-12-07 | 牛津生物疗法有限公司 | It is specific to the antibody of cadherins 17 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041289A (en) * | 1987-11-13 | 1991-08-20 | Becton Dickinson And Company | Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells |
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
US6333152B1 (en) * | 1997-05-21 | 2001-12-25 | The Johnshopkins University | Gene expression profiles in normal and cancer cells |
EP1009766A4 (en) * | 1997-07-01 | 2003-04-09 | Human Genome Sciences | 19 human secreted proteins |
US5929033A (en) * | 1998-02-10 | 1999-07-27 | Incyte Pharmaceuticals, Inc. | Extracellular mucous matrix glycoprotein |
US6183968B1 (en) * | 1998-03-27 | 2001-02-06 | Incyte Pharmaceuticals, Inc. | Composition for the detection of genes encoding receptors and proteins associated with cell proliferation |
EP1080227B1 (en) * | 1998-05-21 | 2006-02-08 | Diadexus, Inc. | Method of diagnosing, monitoring, and staging colon cancer |
WO2000021991A1 (en) * | 1998-10-15 | 2000-04-20 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
JP2002533082A (en) * | 1998-12-23 | 2002-10-08 | コリクサ コーポレイション | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
ES2287020T3 (en) * | 1999-06-02 | 2007-12-16 | Genentech, Inc. | PROCEDURE AND COMPOSITIONS TO INHIBIT THE GROWTH OF NEOPLASSIC CELLS. |
CA2390093A1 (en) * | 1999-12-10 | 2001-06-14 | Incyte Genomics, Inc. | Extracellular matrix and cell adhesion molecules |
-
2000
- 2000-12-29 EP EP00989592A patent/EP1242598A2/en not_active Withdrawn
- 2000-12-29 CA CA002396036A patent/CA2396036A1/en not_active Abandoned
- 2000-12-29 WO PCT/US2000/035596 patent/WO2001049716A2/en not_active Application Discontinuation
- 2000-12-29 AU AU26082/01A patent/AU2608201A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU784548B2 (en) * | 2001-03-16 | 2006-04-27 | Ortho-Clinical Diagnostics, Inc. | Reg-like protein |
Also Published As
Publication number | Publication date |
---|---|
WO2001049716A2 (en) | 2001-07-12 |
CA2396036A1 (en) | 2001-07-12 |
WO2001049716A3 (en) | 2002-01-31 |
EP1242598A2 (en) | 2002-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1144632A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2010699A (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse | |
AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU4185100A (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2608201A (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
AU7484800A (en) | Imaging of scattering media using relative detector values | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU1465801A (en) | Methods for cancer prognosis and diagnosis | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
HUP0200991A2 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
AU6425800A (en) | Agents for the diagnosis, prognosis and treatment of malignant diseases | |
AU6062900A (en) | Substituted indole compounds and their use for the treatment of cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU7817500A (en) | Method of tumor imaging | |
AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2003218208A1 (en) | Methods for diagnosis and prognosis of cancer | |
AU2001266790A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |